Genzyme looks to build sales following growth last year
This article was originally published in Clinica
Executive Summary
Genzyme Tissue Repair's annual revenues increased by 19% to $20.3 million in 1999, led by demand for its Carticel autologous cultured chondrocytes for knee cartilage damage. Total Carticel revenues rose by 38% to $15.1 million.